Introduction
Castleman's disease is a rare lymphoproliferative disorder. Sometimes, physicians get confused of Castleman's disease with other lymphoproliferative disorders. Castleman's disease was first described in a group of patients with benign localised hyperplastic lymph nodes by Castleman et al. In 1965 1, 2 . The excision biopsy itself will help both in the diagnosis and in planning the treatment 3 .
Case History
A 14 year old male, Muslim, student hailing from Bagerhat district was admitted into Department of Medicine, Dhaka Medical College Hospital, Dhaka, on 20th May 2013 with the complaints of multiple nodular painless and discrete swellings in the right side of the neck for one year. According to the statement of the patient he was reasonably well one year back. Then he developed multiple swellings on the right side of the neck which were painless & slowly increasing in size without any discharge. He also complained that he developed on and off low-grade intermittent fever for last one year. He noticed that one of his swellings is gradually increasing in size. Other systemic enquiry revealed no abnormality. For his recent illness he consulted with different local physician and treated with different types of antibiotics. He was undergone FNAC. However, the result was nonspecific. No significant past history was found. He comes from lower middle class family. All his family members are in good health.
On physical examination, his vital signs were normal including an oral temperature of 99 0 F. Enlarged lymph nodes were found on the right side of the neck which were 3 in number, variable in size (larger one 3 cm in diameter) firm in consistency, discrete, non tender, free from overlying skin and underlying structure. There was no discharging sinus. On examination of abdomen there was no organomegaly. Other systemic examination including respiratory system revealed no abnormality.
Laboratory investigation revealed Normal CBC with ESR. PBF showed non-specific findings; urine R/E was normal; serum creatinine: 0.70 mg/dl. Chest x-ray & ECG were normal. HIV screening was Negative. Mantoux test was insignificant. Sputum for AFB was negative. Histopathology study of lymphnode biopsy is consistent with hyaline vascular variant of CD. The patient was treated symptomatically and large 2 lymphnodes were surgically removed. He was completely symptom free for next 6 months in repeated follow-up.
Discussion
Castleman's disease is a disease which involves massive non-malignant proliferation of lymphoid tissues that usually presents as mediastinal masses as well as other groups of lymphnodes 4 . However, some authors described, histologically and prognostically Castleman's disease is distinct from malignant lymph-node hyperplasia. It is also known as angiofollicular lymph-node hyperplasia/giant benign lymphoma / giant lymph-node hyperplasia / lymphoid hamartoma 2 . Castleman disease clinically classified into two main types: 1) localized or unicentric and 2) multicentric 5 . The two main forms are again subdivided based on how the lymph node tissue appears under a microscope. These are called microscopic subtypes. • HIV-association
• Role of IL-6: -High levels of IL-6 are often seen in the multicentric form of CD. But it's not clear what causes the high levels of IL-6. . HHV-8 has also been shown to cause infected cells to make a form of IL-6.
• Role of angiogenesis and vascular endothelial growth factor (VEGF) To treat the patients the following options are adopted:
1) Surgical excision: This is highly recommended for localised and asymptomatic patients.
2) Chemotherapy: Currently, chemotherapy will be the first option chosen in most symptomatic patients. Lots of chemotherapeutic drugs have been tried in different centres. Chemotherapy, ranging from the use of single agents to multidrug combinations, has been tried in different centres; some were successful, some failed. Oral chlorambucil and cyclophosphamide have been effective in some patients, and are generally well tolerated. Single-agent vinblastine 11 , oral etoposide. may also have activity. Single alkylating agent therapy may be most appropriate for the patient who is fragile or in whom a prompt response is not required. Combination chemotherapy regimens that have established roles in NHL, such as cyclophosphamide, vincristine and prednisone (CVP) or cyclophosphamide, doxorubicin, vincristine and prednisone (CHOP), have significant activity. When combination chemotherapy is used, patients need to be carefully selected and closely monitored because of the elevated risk of infection. Patients with HIVassociated Castleman's disease may be at especially high risk for complications with standard combination chemotherapy. Although it is likely that the tolerance of HIV-infected patients would be improved through the use of HAART, potential drug interactions need to be considered. In addition, it has been suggested that the use of HAART may precipitate or exacerbate multicentric Castleman's Disease 8 .
3) Radiation therapy: Radiotherapy does have therapeutic activity and is a treatment option for patients not deemed good surgical candidates or in patients with incomplete surgical excision. The review of the literature documents that radiotherapy has the ability to achieve complete radiographic and clinical resolution of disease in patients with unicentric Castleman's disease.
4) Others:
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